HWAM
MED icon

Hennion & Walsh Asset Management’s Medifast MED Stock Holding History

Hennion & Walsh Asset Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,855
Closed -$214K – 842
2023
Q3 		$214K Sell
2,855
-1,707
-37% -$151K 0.01% 735
2023
Q2 		$420K Sell
4,562
-416
-8% -$37K 0.02% 565
2023
Q1 		$516K Buy
4,978
+394
+9% +$43.7K 0.03% 499
2022
Q4 		$529K Buy
4,584
+2,289
+100% +$267K 0.03% 487
2022
Q3 		$249K Sell
2,295
-311
-12% -$44.6K 0.02% 662
2022
Q2 		$470K Sell
2,606
-101
-4% -$18.1K 0.03% 496
2022
Q1 		$462K Buy
2,707
+159
+6% +$30K 0.02% 530
2021
Q4 		$534K Buy
2,548
+768
+43% +$159K 0.03% 526
2021
Q3 		$343K Buy
+1,780
New +$438K 0.02% 606

Other funds holding MED

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $34.9B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return